264
Participants
Start Date
March 1, 2025
Primary Completion Date
May 1, 2034
Study Completion Date
May 1, 2036
TAVR-explant
Surgical explantation of failed THV followed by surgical aortic valve replacement and any other cardiac surgeries deemed necessary.
Redo-TAVR
Repeat transcatheter aortic valve implantation within a failed THV.
Lead Sponsor
Medstar Health Research Institute
OTHER